About 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine
5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine (PubChem CID 163969058) has the molecular formula C74H105N19O5
and a molecular weight of 1340.78 g/mol. Its IUPAC name is 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine.
Frequently Asked Questions
What is the IUPAC name of 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine?
The IUPAC name of 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine (CID 163969058) is 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine.
What is the SMILES notation for 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine?
The canonical SMILES for 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine is CCCC1=C(C)C2=C(NC1c1cn[nH]c1C)C(OCCN(C)CCOC)=CC1NN=CC21.CCCN1CCOCC1.CCOc1cc2[nH]ncc2c2c3c(c(-c4cn[nH]c4C)nc12)CCCC3.CN1CCNCC1.Cc1[nH]ncc1C1NC2=C(C3=C1CCCC3)C1C=NNC1C=C2O.
What is the InChIKey of 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine?
The InChIKey is SOJQZOGFKHBRRM-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H36N6O2.C20H21N5O.C18H21N5O.C7H15NO.C5H12N2/c1-6-7-17-15(2)22-19-14-26-29-20(19)12-21(32-11-9-30(4)8-10-31-5)24(22)27-23(17)18-13-25-28-16(18)3;1-3-26-17-8-16-15(10-22-25-16)18-12-6-4-5-7-13(12)19(23-20(17)18)14-9-21-24-11(14)2;1-9-12(7-19-22-9)17-11-5-3-2-4-10(11)16-13-8-20-23-14(13)6-15(24)18(16)21-17;1-2-3-8-4-6-9-7-5-8;1-7-4-2-6-3-5-7/h12-14,19-20,23,27,29H,6-11H2,1-5H3,(H,25,28);8-10H,3-7H2,1-2H3,(H,21,24)(H,22,25);6-8,13-14,17,21,23-24H,2-5H2,1H3,(H,19,22);2-7H2,1H3;6H,2-5H2,1H3.
What are the key properties of 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine?
5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine has a molecular weight of 1340.78 g/mol, XLogP of 9.65, 16 rotatable bonds, 10 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;1-methylpiperazine;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine is sourced from PubChem (CID 163969058), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).